CCClaudio Caviezel

Claudio Caviezel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Claudio Caviezel has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Chirurgische oder bronchoskopische Lungenvolumenreduktion zur Emphysemtherapie

    by Claudio Caviezel, Caroline Steinack, Didier Schneiter, Thomas Gaisl, Isabelle Schmitt-Opitz

    Bereits vor über 20 Jahren hat sich die chirurgische Lungenvolumenreduktion (LVRS) bei Patienten mit fortgeschrittenem Lungenemphysem als palliative Therapieoption etabliert, die die Atemnot verringert und die Lungenfunktion und Lebensqualität verbessert. Seit gut 10 Jahren existieren darüber hinaus bronchoskopische Verfahren (BLVR) mit dem Ziel einer Volumenreduktion. Die Vor- und Nachteile von LVRS und BLVR werden in diesem Beitrag diskutiert. More than 20 years ago, surgical lung volume reduction (LVRS) was already established in patients with advanced emphysema as a palliative therapy option that reduces respiratory distress and improves lung function and quality of life. In addition, bronchoscopic procedures (BLVR) aimed at volume reduction have existed for just over 10 years. The advantages and disadvantages of LVRS and BLVR are discussed in this article. Article published online: 21 August 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Open Access

    Relevance of pleural adhesions for short- and long-term outcomes after lung volume reduction surgery

    by Claudio Caviezel, Medea Rodriguez, Pavel Sirotkin, Ulrike Held, Isabelle Opitz, Didier Schneiter


  • Lungenkrebschirurgie bei schwerer COPD mit Emphysem: Tumorresektion mit Verbesserung der Lungenfunktion

    by Aimée Hiller, Didier Schneiter, Isabelle Opitz, Claudio Caviezel

    Zusammenfassung. Die Standardtherapie bei Lungenkrebs im Frühstadium ist die chirurgische, anatomische Resektion, am häufigsten im Sinn einer Lobektomie oder Segmentektomie. Dies setzt die sogenannte Operabiltät voraus, das heisst u.a. gewisse lungenfunktionelle Reserven. Patientinnen und Patienten mit COPD und Emphysem weisen häufig hierfür inakzeptable Lungenfunktionswerte auf. Nichtsdestotrotz kann ihnen eine Operation angeboten werden, wenn sie gleichzeitig für eine Lungenvolumenreduktion (LVRS) qualifizieren. Eine sogenannte Tumorresektion im LVRS-Konzept sichert nicht nur die Diagnose, sondern bietet neben der definitiven Histologie ein korrektes Staging, die komplette Entfernung des Tumors und die Möglichkeit einer postoperativen Verbesserung der Lungenfunktion. Wie bei allen Patientinnen und Patienten mit Krebsverdacht sollte auch hier eine entsprechende Indikation an einem interdisziplinären Tumorboard erfolgen.


  • Perioperative Anaesthesiological Management of Malignant Pleural Mesothelioma Patients Undergoing Extrapleural Pneumonectomy (EPP) and Extended Pleurectomy/Decortication ((E)PD)

    by Olivia Lauk, Corinna Von Deschwanden, Ilhan Inci, Claudio Caviezel, Isabelle Opitz, Bastian Grande

    Malignant pleural mesothelioma,perioperative guidelines,anaesthesiological management,extrapleural pneumonectomy,extended pleurectomy/decortication


  • Open Access

    NiVATS sympathectomy for hyperhidrosis: should I stay or should I go? A Narrative Review

    by Gabriela Haessig, Claudio Caviezel

    Non-intubated video-assisted thoracoscopic surgery (NiVATS) has been shown to be a practicable and beneficial procedure for many thoracic operations. This review summarizes the current literature about NiVATS focusing on patients with hyperhidrosis. Seven studies about NiVATS and its efficacy and/or feasibility have been found and are discussed. There are only two randomized trials, while all other reports are case series. Four studies compare NiVATS with VATS. As seen for many other procedures as wedge resection, pleural biopsy and even anatomical resection, NiVATS sympathectomy for hyperhidrosis is a safe and feasible procedure to perform. Especially, due to the usual young, slim and otherwise healthy patients, this method is well suited to start a NiVATS program. Although NiVATS has a short learning curve, it challenges the whole team including surgeons and anesthesiologists, working on an awake patient. Nevertheless, evidence for clinical advantages of NiVATS compared to VATS is still scarce. The majority of thoracic surgery patients still gets a chest tube for a few days, which might outlast the positive effects of NiVATS, as for example lesser anestesiological trauma. However, there is evidence to show that NiVATS might be suitable in managing thoracoscopic sympathectomy as an outpatient operation, as these patients seem to have a faster general recovery postoperatively.


  • Lung volume reduction surgery as salvage procedure after previous use of endobronchial valves

    by Claudio Caviezel, Laura-Chiara Guglielmetti, Mateja Ladan, Henrik Jessen Hansen, Michael Perch, Didier Schneiter, Walter Weder, Isabelle Opitz, Daniel Franzen

    OBJECTIVES: Lung volume reduction (LVR) is an efficient and approved treatment for selected emphysema patients. There is some evidence that repeated LVR surgery (LVRS) might be beneficial, but there are no current data on LVRS after unsuccessful bronchoscopic LVR (BLVR) with endobronchial valves (EBVs). We hypothesize good outcome of LVRS after BLVR with valves. METHODS: In this study, we retrospectively investigated all patients who underwent LVRS between 2015 and 2019 at 2 centres after previous unsuccessful EBV treatment. They were further divided into subgroups with patients who never achieved the intended improvement after BLVR (primary failure) and patients whose benefit was fading over time due to the natural development of emphysema (secondary failure). Patients with severe air leak after BLVR and immediate concomitant LVRS and fistula closure thereafter were analysed separately. RESULTS: A total of 38 patients were included. Of these, 19 patients had primary failure, 15 secondary failure and 4 were treated as an emergency due to severe air leak. At 3 months after LVRS, forced expiratory volume in 1 s had improved significantly by 12.5% (P = 0.011) and there was no 90-day mortality. Considering subgroups, patients with primary failure after BLVR seem to profit more than those with secondary failure. Patients with severe air leak after BLVR did not profit from fistula closure with concomitant LVRS. CONCLUSIONS: LVRS after previous BLVR with EBVs can provide significant clinical improvement with low morbidity, although results might not be as good as after primary LVRS.


  • Open Access

    Case report of sequential bilateral spontaneous pneumothorax in a never-ventilated, lung-healthy COVID-19-patient

    by Claudio Caviezel, Lina Weiss, Gabriela Haessig, Christian Alfaré, Martina Haberecker, Zsuzsanna Varga, Thomas Frauenfelder, Isabelle Opitz

    Introduction: Patients with COVID-19 infection and severe lung parenchyma alterations may need mechanical ventilation with subsequent pneumothorax and eventually persistent air leak in case of pre-existing lung disease. Presentation of case: This report presents the case of a never-ventilated 58 years old male patient without pre-existing, underlying lung disease demonstrating severe lung parenchyma changes due to COVID-19-pneumonia. He suffered from recurrent bilateral spontaneous pneumothoraces, which were successfully treated with bilateral thoracoscopy and resections of the destroyed lung areas. Notably, he has already been under treatment with anticoagulation due to portal thrombosis 8 years ago. Discussion: Although especially know from patients under mechanical ventilation, this patient suffered from spontaneous pneumothorax without ever been ventilated. Probably due to the severe vascular inflammatory changes and focal endothelitis like also seen in other organs of COVID-19 patients, the pneumothorax may lead to a prolonged air leak, which needs surgical therapy. The patients pre-existing anticoagulation therapy may prevented him from a mere severe course. Conclusion: Early surgical therapy may be considered in COVID-19 patients with persistent air leak, even if not mechanically ventilated. Simultaneously, the role of early anticoagulation needs further investigation. Highlights:


  • Open Access

    Nonintubated surgical biopsy of undetermined interstitial lung disease: a multicentre outcome analysis

    by Eugenio Pompeo, Paola Rogliani, Cansel Atinkaya, Francesco Guerrera, Enrico Ruffini, Marco Antonio Iñiguez-Garcia, Michael Peer, Luca Voltolini, Claudio Caviezel, Walter Weder, et al.

    Nonintubated surgical biopsy (NISB) of interstitial lung disease (ILD) has shown promise in unicentre reports as a reliable method to achieve pathological diagnosis with low morbidity. The aim of this study was to investigate for the first time early outcomes of NISB of ILD using a multicentre retrospective analysis. Seven European and extra-European institutions participated in the study. Overall, 112 procedures were included. The mean age was 60 ± 12 years (65 men and 47 women). Preoperative total lung capacity and diffusion capacity of carbon monoxide were 74 ± 16% predicted and 57 ± 18% predicted, respectively. Forty-five patients had 1 or more associated comorbidities. NISB of ILD were performed under spontaneous ventilation by intercostal block (n = 84) or epidural anaesthesia (n = 28) with (n = 58) or without (n = 54) sedation and by thoracoscopic surgery (n = 88) or minithoracotomy (n = 24). Mean anaesthesia time, operative time and global time spent in the operating room were 31 ± 31 min, 29 ± 15 min and 89 ± 156 min, respectively. Feasibility was scored as excellent, good, satisfactory or unsatisfactory requiring conversion to general anaesthesia with intubation in 92, 12, 2 and 6 instances, respectively. There were no deaths. Morbidity was 7.1% and included prolonged air leaks in 4 patients and pneumonia, atelectasis, anaemia and gastric bleeding in 1 patient each. A precise pathological diagnosis was achieved in 108 patients (96%). The mean hospital stay was 2.5 ± 2.7 days. Comparisons of results achieved in the largest single-centre series (group A, 60 patients operated on) versus those resulting from the sum of the patients operated on in the other centres (group B, 52 patients operated on) showed no differences in feasibility (P = 0.10) and morbidity (P = 0.10) whereas hospital stay was shorter in group A (1.3 ± 0.5 days vs 3.9 ± 3.4 days, P < 0.001). Results of this multicentre study confirm the satisfactory feasibility of NISB of ILD in 82% of patients with no deaths and a low morbidity rate. Intergroup comparisons indicated that the hospital stay was shorter in group A whereas there were no differences in feasibility and morbidity rates.


  • Open Access

    Improved postoperative lung function after sublobar resection of non-small-cell lung cancer combined with lung volume reduction surgery in patients with advanced emphysema

    by Claudio Caviezel, Julia von Rotz, Didier Schneiter, Ilhan Inci, Sven Hillinger, Isabelle Opitz, Walter Weder

    Background: Radiotherapy is recommended as primary local therapy for inoperable patients with non-small cell lung cancer (NSCLC). We hypothesized that selected patients with advanced emphysema could be candidates for surgery and improved functional outcome might result in addition to low mortality and morbidity and successful cancer control when sublobar resection in a lung volume reduction surgery (LVRS) concept is applied. Methods: All patients with NSCLC and severe emphysema who underwent cancer resection in a LVRS concept between 2003 and 2015 were included for analysis. Postoperative 90-day mortality, complications, survival and lung function with forced expiratory volume in one second pre-operatively and three months postoperatively served as endpoints. Results: Fourteen patients were included. Three procedures were bilateral and eleven unilateral, eight have been performed with thoracoscopy and six with conversion to an open procedure due to adhesions. In ten patients, tumor resection was atypical and in four patients an anatomic segmentectomy was performed. All patients had lung volume reduction. Prolonged air leak occurred in three patients. Perioperative 90-mortality was zero. Median pre-operative forced expiratory volume in one second was 32.5% and increased to 37% (P=0.002) 3 months following surgery. Three and 5-year survival rates were 50% and 35%, respectively. Conclusions: Sublobar resection of NSCLC combined with LVRS in patients with severely impaired lung function due to emphysema can be performed with low mortality and morbidity making it an alternative treatment modality to radiotherapy. This approach allows cancer resection in marginal patients and improves emphysema symptoms simultaneously.


  • Recognizing the strange: experience of the ESTS-AME clinical fellowship in Beijing and Guangzhou

    by Claudio Caviezel

    Recognizing the strange: experience of the ESTS-AME clinical fellowship in Beijing and Guangzhou